Lovedeep Singh Dhingra

Oct 7, 2024 | medrxiv.org | Lovedeep Singh Dhingra |Arya Aminorroaya |Aline Pedroso Camargos |Sumukh Vasisht Shankar

Dr. Khera is an Associate Editor of JAMA. Dr. Khera and Mr. Sangha are the coinventors of U.S. Provisional Patent Application No. 63/346,610, "Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning" and are co-founders of Ensight-AI.

May 27, 2024 | medrxiv.org | Lovedeep Singh Dhingra |Arya Aminorroaya |Aline Pedroso Camargos |Akshay Khunte

Dr. Khera is an Associate Editor of JAMA. Dr. Khera and Mr. Sangha are the coinventors of U.S. Provisional Patent Application No. 63/346,610, "Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning" and are co-founders of Ensight-AI.

Apr 3, 2024 | medrxiv.org | Lovedeep Singh Dhingra |Arya Aminorroaya |Aline Pedroso Camargos |Folkert W. Asselbergs

Dr. Khera is an Associate Editor of JAMA. Dr. Khera and Mr. Sangha are the coinventors of U.S. Provisional Patent Application No. 63/346,610, "Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning" and are co-founders of Ensight-AI.

Mar 19, 2024 | medrxiv.org | Arya Aminorroaya |Lovedeep Singh Dhingra |Aline Pedroso Camargos |Sumukh Vasisht Shankar

Dr. Khera is an Associate Editor of JAMA. He receives support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (under awards R01HL167858 and K23HL153775) and the Doris Duke Charitable Foundation (under award 2022060). He also receives research support, through Yale, from Bristol-Myers Squibb, Novo Nordisk, and BridgeBio.

Mar 15, 2024 | medrxiv.org | Evangelos Oikonomou |Lovedeep Singh Dhingra |Arya Aminorroaya |Andreas C. Coppi

R.K. is an Associate Editor of JAMA and receives research support, through Yale, from the Blavatnik Foundation, Bristol-Myers Squibb, Novo Nordisk, and BridgeBio. He is a coinventor of U.S. Provisional Patent Applications 63/177,117, 63/428,569, 63/346,610, 63/484,426, and 63/508,315, and a co-founder of Ensight-AI, Inc. R.K. and E.K.O. are co-founders of Evidence2Health, a health analytics company.